Fungal Keratitis Treatment Market
Fungal Keratitis Treatment Market Forecasts to 2030 - Global Analysis By Keratitis Type (Aspergillus Keratitis, Candida Keratitis and Fungal Species), Treatment, Route of Administration, Mode of Action, Distribution Channel and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $0.9 BN |
|
Projected Year Value (2030) |
US $1.6 BN |
|
CAGR (2023 - 2030) |
9.0% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
Asia Pacific |
|
Highest Growing Market |
North America |
According to Stratistics MRC, the Global Fungal Keratitis Treatment Market is accounted for $0.9 billion in 2023 and is expected to reach $1.6 billion by 2030 growing at a CAGR of 9.0% during the forecast period. Fungal keratitis, a serious eye infection, typically requires prompt and specific treatment. Antifungal eye drops, such as voriconazole or natamycin, are the mainstay of therapy. In severe cases, oral antifungal medications may be prescribed. Treatment duration can vary but often lasts several weeks to months. In addition to medication, supportive measures like frequent eye irrigation and debridement of infected tissue may be necessary. Close monitoring by an ophthalmologist is crucial to assess treatment response and prevent complications like corneal scarring or perforation.
According to an article published by the National Library of Medicine in March 2023, the demand for improved diagnostic methods for fungal keratitis was driven by the limitations of current techniques, such as the cultural method and direct microscopy with staining, which may need revision for timely and accurate identification.
Market Dynamics:
Driver:
Rising prevalence of fungal keratitis
A higher prevalence of fungal keratitis leads to a larger patient population requiring treatment, thereby expanding the overall market size for fungal keratitis treatments. This growth presents opportunities for pharmaceutical companies and increased research and development efforts aimed at discovering innovative treatment modalities, including novel antifungal drugs, combination therapies, and advanced delivery systems to develop and commercialize new therapies to meet the rising demand.
Restraint:
Lack of awareness
Without proper awareness, patients and healthcare providers may misdiagnose fungal keratitis as other ocular conditions, leading to inappropriate treatment with antibiotics or other medications ineffective against fungal infections. Moreover, patients who are unaware of the signs and symptoms of fungal keratitis may not seek medical attention promptly, resulting in underutilization of available treatment options. This mismanagement can exacerbate the infection and prolong recovery, negatively affecting the market for targeted antifungal treatments.
Opportunity:
Advances in diagnostic tools
Precision diagnostics allow for personalized treatment approaches tailored to the specific fungal pathogen causing the infection. By identifying the fungal species involved and assessing its susceptibility to antifungal agents, clinicians can select the most effective treatment regimen, minimizing the risk of treatment failure and antifungal resistance. Advanced diagnostic tools, such as in vivo confocal microscopy, polymerase chain reaction (PCR) assays, and molecular testing, enable early detection and accurate diagnosis of fungal keratitis. This early identification facilitates prompt initiation of appropriate treatment, improving patient outcomes and driving demand for antifungal medications.
Threat:
Emergence of antifungal-resistant strains
Antifungal resistance reduces the effectiveness of conventional treatment options, limiting the available therapeutic choices for fungal keratitis. Healthcare providers may face challenges in managing infections caused by resistant strains, leading to treatment failures and prolonged disease duration. These cases require more intensive medical management, including specialized diagnostic testing, prolonged treatment courses, and closer monitoring. This allocation of healthcare resources towards managing resistant infections can strain healthcare systems and impact overall patient care delivery.
Covid-19 Impact
While healthcare resources have been diverted to combat the virus, leading to delays in non-emergency eye care, increased awareness of hygiene measures may have reduced the incidence of fungal keratitis. However, disruptions in supply chains and healthcare services may have affected access to antifungal medications and ophthalmic care, potentially impacting treatment outcomes. Additionally, the use of face masks and prolonged use of contact lenses during the pandemic could have contributed to an increase in fungal keratitis cases.
The aspergillus keratitis segment is expected to be the largest during the forecast period
The aspergillus keratitis segment is estimated to have a lucrative growth, because aspergillus keratitis often presents unique challenges in treatment due to its resistance to certain antifungal medications and the potential for rapid progression. This complexity may necessitate the development of specialized treatment approaches and novel therapeutic agents tailored to combat Aspergillus infections specifically. Pharmaceutical companies and researchers may focus on developing antifungal drugs with improved efficacy against Aspergillus, leading to innovation in the fungal keratitis treatment market.
The antifungal medications segment is expected to have the highest CAGR during the forecast period
The antifungal medications segment is anticipated to witness the highest CAGR growth during the forecast period, owing to the development and availability of different classes of antifungal medications offer healthcare providers a diverse range of treatment options for fungal keratitis. This diversity fosters competition among pharmaceutical companies, leading to innovation and the introduction of new formulations or drug combinations. As these medications provide essential therapeutic options for patients, the market expands to meet the demand.
Region with largest share:
Asia Pacific is projected to hold the largest market share during the forecast period owing to the incidence of fungal keratitis varies across different regions within the Asia Pacific, with factors such as climate, agricultural practices, and hygiene standards playing a role. Further variances in healthcare infrastructure and access to ophthalmic care across countries within the Asia Pacific region can impact the diagnosis and treatment of fungal keratitis.
Region with highest CAGR:
North America is projected to have the highest CAGR over the forecast period, as North America boasts advanced healthcare infrastructure, including well-equipped hospitals, specialized eye care centers, and skilled healthcare professionals, contributing to timely diagnosis and treatment of fungal keratitis and the region is at the forefront of technological innovations in ophthalmology, leading to the development of advanced diagnostic tools, therapeutic agents, and surgical techniques for the treatment of fungal keratitis.
Key players in the market
Some of the key players in the Fungal Keratitis Treatment Market include AbbVie Inc., Alvogen, Aurolab, Bausch Health, Cipla Inc., Eyevance Pharmaceuticals LLC, Gilead Biosciences, Inc., Glenmark Pharmaceuticals, Leadiant Biosciences, Lexicare Pharma Pvt. LTD, Mallinckrodt LLC, Merck & Co. Inc., Novartis AG, Novo Holdings A/S, Ora, Inc., Pfizer Inc., Salvus Pharma, Santen Pharmaceutical Co., Ltd. And Wellona Pharma
Key Developments:
In April 2024, Bausch Health, Canada Inc. announces first public drug plan listings for PrUCERIS® (budesonide) aerosol foam to help address the unmet need for the treatment of mild to moderate distal ulcerative colitis in adults.
In March 2024, Allergan Aesthetics Launches ""Moving the Needle on Ethics"" to Elevate the Conversation Around Ethics in Aesthetics. The collection of interviews highlights the need for industry-wide transparency and integrity to meet the expected increase in global demand for aesthetics treatments.
In March 2024, AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases. Landos' lead investigational asset is NX-13, a first-in-class, oral NLRX1 agonist (a member of the NOD-like receptor family) with a bimodal mechanism of action (MOA), which is anti-inflammatory and facilitates epithelial repair.
Keratitis Types Covered:
• Aspergillus Keratitis
• Candida Keratitis
• Fungal Species
Treatments Covered:
• Antifungal Medications
• Surgery
• Adjunctive Therapies
• Combination Therapy
• Other Treatments
Route of Administrations Covered:
• Topical
• Oral
• Intravenous
Mode of Actions Covered:
• Fungicidal
• Fungistatic
Distribution Channels Covered:
• Specialty Clinics
• Hospitals
• Retail Pharmacies
• Online Pharmacies
• Other Distribution Channels
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
3.7 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Fungal Keratitis Treatment Market, By Keratitis Type
5.1 Introduction
5.2 Aspergillus Keratitis
5.3 Candida Keratitis
5.4 Fungal Species
6 Global Fungal Keratitis Treatment Market, By Treatment
6.1 Introduction
6.2 Antifungal Medications
6.2.1 Polyenes
6.2.2 Azoles
6.2.3 Echinocandins
6.2.4 Other Antifungal Medications
6.3 Surgery
6.3.1 Corneal Debridement
6.3.2 Corneal Transplantation
6.3.3 Therapeutic Penetrating Keratoplasty
6.3.4 Amniotic Membrane Transplantation
6.4 Adjunctive Therapies
6.5 Combination Therapy
6.6 Other Treatments
7 Global Fungal Keratitis Treatment Market, By Route of Administration
7.1 Introduction
7.2 Topical
7.3 Oral
7.4 Intravenous
8 Global Fungal Keratitis Treatment Market, By Mode of Action
8.1 Introduction
8.2 Fungicidal
8.3 Fungistatic
9 Global Fungal Keratitis Treatment Market, By Distribution Channel
9.1 Introduction
9.2 Specialty Clinics
9.3 Hospitals
9.4 Retail Pharmacies
9.5 Online Pharmacies
9.6 Other Distribution Channels
10 Global Fungal Keratitis Treatment Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 AbbVie Inc.
12.2 Alvogen
12.3 Aurolab
12.4 Bausch Health
12.5 Cipla Inc.
12.6 Eyevance Pharmaceuticals LLC
12.7 Gilead Biosciences, Inc.
12.8 Glenmark Pharmaceuticals
12.9 Leadiant Biosciences
12.10 Lexicare Pharma Pvt. LTD
12.11 Mallinckrodt LLC
12.12 Merck & Co. Inc.
12.13 Novartis AG
12.14 Novo Holdings A/S
12.15 Ora, Inc.
12.16 Pfizer Inc.
12.17 Salvus Pharma
12.18 Santen Pharmaceutical Co., Ltd.
12.19 Wellona Pharma
List of Tables
1 Global Fungal Keratitis Treatment Market Outlook, By Region (2021-2030) ($MN)
2 Global Fungal Keratitis Treatment Market Outlook, By Keratitis Type (2021-2030) ($MN)
3 Global Fungal Keratitis Treatment Market Outlook, By Aspergillus Keratitis (2021-2030) ($MN)
4 Global Fungal Keratitis Treatment Market Outlook, By Candida Keratitis (2021-2030) ($MN)
5 Global Fungal Keratitis Treatment Market Outlook, By Fungal Species (2021-2030) ($MN)
6 Global Fungal Keratitis Treatment Market Outlook, By Treatment (2021-2030) ($MN)
7 Global Fungal Keratitis Treatment Market Outlook, By Antifungal Medications (2021-2030) ($MN)
8 Global Fungal Keratitis Treatment Market Outlook, By Polyenes (2021-2030) ($MN)
9 Global Fungal Keratitis Treatment Market Outlook, By Azoles (2021-2030) ($MN)
10 Global Fungal Keratitis Treatment Market Outlook, By Echinocandins (2021-2030) ($MN)
11 Global Fungal Keratitis Treatment Market Outlook, By Other Antifungal Medications (2021-2030) ($MN)
12 Global Fungal Keratitis Treatment Market Outlook, By Surgery (2021-2030) ($MN)
13 Global Fungal Keratitis Treatment Market Outlook, By Corneal Debridement (2021-2030) ($MN)
14 Global Fungal Keratitis Treatment Market Outlook, By Corneal Transplantation (2021-2030) ($MN)
15 Global Fungal Keratitis Treatment Market Outlook, By Therapeutic Penetrating Keratoplasty (2021-2030) ($MN)
16 Global Fungal Keratitis Treatment Market Outlook, By Amniotic Membrane Transplantation (2021-2030) ($MN)
17 Global Fungal Keratitis Treatment Market Outlook, By Adjunctive Therapies (2021-2030) ($MN)
18 Global Fungal Keratitis Treatment Market Outlook, By Combination Therapy (2021-2030) ($MN)
19 Global Fungal Keratitis Treatment Market Outlook, By Other Treatments (2021-2030) ($MN)
20 Global Fungal Keratitis Treatment Market Outlook, By Route of Administration (2021-2030) ($MN)
21 Global Fungal Keratitis Treatment Market Outlook, By Topical (2021-2030) ($MN)
22 Global Fungal Keratitis Treatment Market Outlook, By Oral (2021-2030) ($MN)
23 Global Fungal Keratitis Treatment Market Outlook, By Intravenous (2021-2030) ($MN)
24 Global Fungal Keratitis Treatment Market Outlook, By Mode of Action (2021-2030) ($MN)
25 Global Fungal Keratitis Treatment Market Outlook, By Fungicidal (2021-2030) ($MN)
26 Global Fungal Keratitis Treatment Market Outlook, By Fungistatic (2021-2030) ($MN)
27 Global Fungal Keratitis Treatment Market Outlook, By Distribution Channel (2021-2030) ($MN)
28 Global Fungal Keratitis Treatment Market Outlook, By Specialty Clinics (2021-2030) ($MN)
29 Global Fungal Keratitis Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
30 Global Fungal Keratitis Treatment Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
31 Global Fungal Keratitis Treatment Market Outlook, By Online Pharmacies (2021-2030) ($MN)
32 Global Fungal Keratitis Treatment Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
